KR890701101A - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
KR890701101A
KR890701101A KR1019890700007A KR890700007A KR890701101A KR 890701101 A KR890701101 A KR 890701101A KR 1019890700007 A KR1019890700007 A KR 1019890700007A KR 890700007 A KR890700007 A KR 890700007A KR 890701101 A KR890701101 A KR 890701101A
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
KR1019890700007A
Other languages
Korean (ko)
Other versions
KR960011236B1 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority claimed from GB878710966A external-priority patent/GB8710966D0/en
Priority claimed from GB878710965A external-priority patent/GB8710965D0/en
Publication of KR890701101A publication Critical patent/KR890701101A/en
Application granted granted Critical
Publication of KR960011236B1 publication Critical patent/KR960011236B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
KR1019890700007A 1987-05-08 1987-05-04 Pharmaceutical compositions of cimetidine KR960011236B1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB878710966A GB8710966D0 (en) 1987-05-08 1987-05-08 Pharmaceutical compositions
GB8710965 1987-05-08
GB878710965A GB8710965D0 (en) 1987-05-08 1987-05-08 Pharmaceutical compositions
GB8710966 1987-05-08
PCT/GB1988/000349 WO1988008703A1 (en) 1987-05-08 1988-05-04 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
KR890701101A true KR890701101A (en) 1989-12-19
KR960011236B1 KR960011236B1 (en) 1996-08-21

Family

ID=26292225

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890700007A KR960011236B1 (en) 1987-05-08 1987-05-04 Pharmaceutical compositions of cimetidine

Country Status (12)

Country Link
US (1) US5188839A (en)
EP (1) EP0290229B1 (en)
JP (1) JP2721219B2 (en)
KR (1) KR960011236B1 (en)
AU (1) AU602582B2 (en)
DE (1) DE3863963D1 (en)
ES (1) ES2040339T3 (en)
GB (1) GB2204489B (en)
GR (1) GR3002410T3 (en)
IE (1) IE61692B1 (en)
PT (1) PT87423B (en)
WO (1) WO1988008703A1 (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286489A (en) * 1985-08-26 1994-02-15 The Procter & Gamble Company Taste masking compositions
GB8710965D0 (en) * 1987-05-08 1987-06-10 Smith Kline French Lab Pharmaceutical compositions
DE3809764A1 (en) * 1988-03-23 1989-10-05 Knoll Ag MIXTURE OF ALGINATES AND POLYACRYLATES AND THEIR USE
US5230901A (en) * 1988-03-23 1993-07-27 Knoll Ag Sustained release tablet of a mixture of alginates and polyacrylates
ATE82680T1 (en) * 1988-05-04 1992-12-15 Smith Kline French Lab CHEWABLE TABLET.
US5219563A (en) * 1988-05-11 1993-06-15 Glaxo Group Limited Drug adsorbates
DE3931215C2 (en) * 1988-09-20 1998-07-16 Glaxo Group Ltd Pharmaceutical preparations based on ranitidine
ZA919510B (en) * 1990-12-05 1992-10-28 Smithkline Beecham Corp Pharmaceutical compositions
DE69233130T2 (en) * 1991-05-28 2005-06-02 Mcneil-Ppc, Inc. COUGAR COMPOSITION FOR MEDICINAL RELEASE
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
EG20380A (en) * 1991-10-16 1999-02-28 Richardson Vicks Inc Enhanced skin penetration system for improved topical delivery of drugs
GB9127150D0 (en) * 1991-12-20 1992-02-19 Smithkline Beecham Plc Novel treatment
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
WO1993024109A1 (en) * 1992-06-04 1993-12-09 Smithkline Beecham Corporation Palatable pharmaceutical compositions
GB9224855D0 (en) * 1992-11-27 1993-01-13 Smithkline Beecham Plc Pharmaceutical compositions
CA2110313C (en) * 1992-12-01 2004-10-26 Edward John Roche Pharmaceutical compositions containing a guanidinothiazole compound and antacids
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6676967B1 (en) * 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
SE9600071D0 (en) † 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
PL187242B1 (en) 1996-05-13 2004-06-30 Novartis Consumer Health Sa Buccal delivery system
DE69739967D1 (en) * 1996-06-14 2010-09-30 Kyowa Hakko Kirin Co Ltd A rapidly disintegrating tablet in the mouth
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US5989588A (en) * 1996-10-04 1999-11-23 Merck & Co., Inc. Methods and compositions for preventing and treating heartburn
WO1998014198A1 (en) * 1996-10-04 1998-04-09 Merck & Co., Inc. Methods and compositions for preventing and treating heartburn
FR2766089B1 (en) † 1997-07-21 2000-06-02 Prographarm Lab IMPROVED MULTIPARTICULAR TABLET WITH RAPID DELIVERY
IN186245B (en) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
WO2000028988A1 (en) * 1998-11-17 2000-05-25 Nitromed, Inc. Nitrosated and nitrosylated h2 receptor antagonist compounds, compositions and methods of use
FR2794979B1 (en) * 1999-06-21 2001-07-27 Patrick Veret A NEW FORMULATION OF TABLET COMPOSED OF LACTOSE, SORBITOL, MAGNESIUM STEARATE
DK1276470T3 (en) 2000-04-20 2007-06-18 Novartis Ag Flavor-crushing coating composition
US6551617B1 (en) 2000-04-20 2003-04-22 Bristol-Myers Squibb Company Taste masking coating composition
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
WO2003075829A2 (en) * 2002-03-08 2003-09-18 M/S. Ind-Swift Limited Tasteless directly compressible fast-dissolving complexes and pharmaceutical formulations thereof
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
ITMI20041255A1 (en) * 2004-06-22 2004-09-22 Univ Degli Studi Milano MICROPARTICLE SYSTEMS FOR ORAL ADMINISTRATION OF BIOLOGICALLY ACTIVE SUBSTANCES
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US20060127479A1 (en) * 2004-10-08 2006-06-15 Natrajan Kumaraperumal Solvent free taste masked pharmaceutical compositions
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ589750A (en) 2004-10-21 2012-07-27 Aptalis Pharmatech Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
EP1983827A4 (en) 2006-02-01 2013-07-10 Stuart L Weg Use of antifungal compositions to treat upper gastrointestinal conditions
JP5309262B2 (en) 2009-12-02 2013-10-09 アプタリス ファーマ リミテッド Fexofenadine microcapsule and composition containing the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5840529B2 (en) * 1975-09-29 1983-09-06 明治製菓株式会社 Keikouyou Seizaino Seiho
JPS5513239A (en) * 1978-07-14 1980-01-30 Fujisawa Pharmaceut Co Ltd Fine particulate drug composition
JPS5567375A (en) * 1978-11-17 1980-05-21 Harunobu Miura Automatic washer
JPS56164122A (en) * 1980-05-21 1981-12-17 Fujimoto Seiyaku Kk Drug composition comprising cimetidine as main agent
JPS58201725A (en) * 1982-05-19 1983-11-24 Eisai Co Ltd Composition for preventing browning
DE3681348D1 (en) * 1985-06-11 1991-10-17 Teijin Ltd ORAL DRUG PREPARATION WITH RETARDIVE EFFECT.
FR2593065B1 (en) * 1986-01-22 1988-09-09 Smith Kline French Lab EFFERVESCENT COUPLES, EFFERVESCENT COMPOSITIONS OF HISTAMINE H2 ANTAGONISTS CONTAINING THEM AND THEIR PREPARATION.
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
JPS63188621A (en) * 1987-01-30 1988-08-04 Taisho Pharmaceut Co Ltd Flavor oral preparation
GB8710965D0 (en) * 1987-05-08 1987-06-10 Smith Kline French Lab Pharmaceutical compositions

Also Published As

Publication number Publication date
EP0290229B1 (en) 1991-07-31
GR3002410T3 (en) 1992-12-30
IE61692B1 (en) 1994-11-16
AU1714088A (en) 1988-12-06
GB8810477D0 (en) 1988-06-08
JPH01503385A (en) 1989-11-16
WO1988008703A1 (en) 1988-11-17
PT87423A (en) 1989-05-31
JP2721219B2 (en) 1998-03-04
DE3863963D1 (en) 1991-09-05
PT87423B (en) 1992-09-30
KR960011236B1 (en) 1996-08-21
ES2040339T3 (en) 1993-10-16
US5188839A (en) 1993-02-23
EP0290229A1 (en) 1988-11-09
IE881368L (en) 1988-11-08
AU602582B2 (en) 1990-10-18
GB2204489A (en) 1988-11-16
GB2204489B (en) 1990-11-14

Similar Documents

Publication Publication Date Title
SE8801813L (en) PHARMACEUTICAL COMPOSITION
KR890701101A (en) Pharmaceutical composition
DE122004000023I2 (en) Pharmaceutical composition
DK89090D0 (en) PHARMACEUTICAL PREPARATION
DK100488A (en) PHARMACEUTICAL PLASTER
DK705488D0 (en) PHARMACEUTICAL PREPARATION
FI883673A0 (en) PHARMACEUTICAL COMPOSITION.
IT1209615B (en) PHARMACEUTICAL COMPOSITION
IT1217446B (en) OPHTHALMOLOGICAL COMPOSITION
BR8805753A (en) COMPOSITION
DK139388A (en) PHARMACEUTICAL PREPARATION
BR8805083A (en) COMPOSITION
MX11584A (en) PHARMACEUTICAL COMPOSITIONS
IT1216814B (en) PHARMACEUTICAL COMPOSITIONS
DK181588A (en) SHAMPOO COMPOSITION
BR8806938A (en) OLEAGINOSA COMPOSITION
IT1203737B (en) PHARMACEUTICAL COMPOSITIONS INCLUDING 3-AMINOPROPOSSI-INDOLI
IT1224244B (en) ANOREXIZING PHARMACEUTICAL COMPOSITION INCLUDING 5-IDROSSITRPOFANO
DK138888D0 (en) PHARMACEUTICAL PREPARATION
SE8705100D0 (en) PHARMACEUTICAL COMPOSITION
SE8700576D0 (en) PHARMACEUTICAL COMPOSITION
IT9020332A0 (en) PHARMACEUTICAL COMPOSITION
SE8904063D0 (en) PHARMACEUTICAL COMPOSITION
DK726488A (en) PHARMACEUTICAL AGENTS
DK726588D0 (en) PHARMACEUTICAL AGENTS

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20100729

Year of fee payment: 15

EXPY Expiration of term